Biocon

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE376G01013
  • NSEID: BIOCON
  • BSEID: 532523
INR
366.00
3.65 (1.01%)
BSENSE

Nov 20

BSE+NSE Vol: 15.48 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 201791,
    "name": "Biocon",
    "stock_name": "Biocon",
    "full_name": "Biocon Ltd.",
    "name_url": "stocks-analysis/biocon",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "366.00",
    "chg": 3.65,
    "chgp": "1.01%",
    "dir": 1,
    "prev_price": "362.35",
    "mcapval": "59,101.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 532523,
    "symbol": "BIOCON",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE376G01013",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "15.48 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/biocon-201791-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Biocon Ltd. is Rated Sell by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/biocon-ltd-is-rated-sell-by-marketsmojo-4261319",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/BioconLtd_mojoScore_4261319.png",
        "date": "2026-11-14 10:10:41",
        "description": "Biocon Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 November 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 November 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Biocon Gains 3.69% This Week: Earnings Slump and Intraday Rally Shape the Story",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/biocon-gains-369-this-week-earnings-slump-and-intraday-rally-shape-the-story-4256211",
        "imagepath": "",
        "date": "2026-11-08 14:00:10",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Nov:</strong> Stock opens at Rs.353.85 with modest gains</p>\n                    <p><strong>3 Nov:</strong> Sharp decline of 2.97% amid broader market gains</p>\n                    <p><strong>5 Nov:</strong> Intraday high of Rs.363.40 with 5.28% surge; Q2 earnings reveal sharp profit decline</p>\n                    <p><strong>6 Nov:</strong> Week closes at Rs.365.00, up 1.00% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.352.00</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-v..."
      },
      {
        "title": "Biocon Ltd. Rallies 5.28% and Approaches 50 DMA Resistance — A Key Technical Test Ahead",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/biocon-ltd-hits-intraday-high-with-528-surge-on-5-nov-2026-4252296",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/BioconLtd_priceRelatedfactors_4252296.png",
        "date": "2026-11-05 10:41:27",
        "description": "The Sensex gained 1.85% on 05 Nov 2026, yet Biocon Ltd. outperformed with a 5.28% surge, touching an intraday high of Rs 363.4. That 3.43-percentage-point outperformance signals a stock-specific strength rather than a mere market tailwind."
      },
      {
        "title": "Biocon Ltd Q2 2026 Earnings Reveal Sharp Decline Amid Negative Financial Trend",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/biocon-ltd-q2-2026-earnings-reveal-sharp-decline-amid-negative-financial-trend-4251061",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/BioconLtd_fintrenddot_4251061.png",
        "date": "2026-11-05 08:00:13",
        "description": "Biocon Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has reported a marked deterioration in its latest quarterly financial performance, signalling a shift from a previously flat trend to a distinctly negative trajectory. Despite a robust growth in profit after tax over the last six months, the September 2026 quarter results reveal significant contraction in key profitability metrics, raising concerns among investors and analysts alike."
      },
      {
        "title": "Biocon Ltd Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/biocon-ltd-sees-sharp-open-interest-surge-amid-mixed-market-signals-4239645",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/BioconLtd_oi_spurts_by_underlying_4239645.png",
        "date": "2026-10-26 15:00:09",
        "description": "Biocon Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant 24.46% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite trading near its 52-week low, the stock outperformed its sector on 26 Oct 2026, reflecting a complex interplay of cautious optimism and strategic bets among traders."
      },
      {
        "title": "Biocon Ltd Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/biocon-ltd-sees-sharp-open-interest-surge-amid-mixed-market-signals-4239562",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/BioconLtd_oi_spurts_by_underlying_4239562.png",
        "date": "2026-10-26 14:00:10",
        "description": "Biocon Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 18% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite trading near its 52-week low, the stock’s recent uptick after a prolonged decline and increased delivery volumes suggest a complex interplay of cautious optimism and speculative bets among traders."
      },
      {
        "title": "Biocon Ltd. Declines 6.69%: Four Key Factors Behind the Steep Weekly Drop",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/biocon-ltd-declines-669-four-key-factors-behind-the-steep-weekly-drop-4237993",
        "imagepath": "",
        "date": "2026-10-25 14:00:37",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Oct 19:</strong> Technical momentum shifts to bearish amid market pressure</p>\n                    <p><strong>Oct 21:</strong> Stock falls to 52-week low of Rs.337.7</p>\n                    <p><strong>Oct 22:</strong> New 52-week low of Rs.328.65 recorded</p>\n                    <p><strong>Oct 23:</strong> Week closes at Rs.326.60 after fresh 52-week low of Rs.327</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.340.50</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.326.60</div><div..."
      },
      {
        "title": "Biocon Ltd. is Rated Sell by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/biocon-ltd-is-rated-sell-by-marketsmojo-4235265",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/BioconLtd_mojoScore_4235265.png",
        "date": "2026-10-23 10:10:03",
        "description": "Biocon Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 October 2026, providing investors with the most up-to-date insight into the company’s performance and outlook."
      },
      {
        "title": "Biocon Ltd. Falls to 52-Week Low of Rs 337.7 Amidst Mixed Financial Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/biocon-ltd-stock-falls-to-52-week-low-of-rs3377-amidst-continued-downtrend-4232186",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/BioconLtd_priceRelatedfactors_4232186.png",
        "date": "2026-10-21 10:37:04",
        "description": ""
      }
    ],
    "total": 132,
    "sid": "201791",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/biocon-201791"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "18-Nov-2026",
      "details": "Press Release",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "16-Nov-2026",
      "details": "Press Release",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "11-Nov-2026",
      "details": "Intimation on Schedule of Meetings with Analyst(s)/institutional Investor(s)",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Biocon Ltd. has declared <strong>10%</strong> dividend, ex-date: 03 Jul 26",
          "dt": "2026-07-03",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Biocon Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 12 Jun 19",
          "dt": "2019-06-12",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Press Release / Media Release

18-Nov-2026 | Source : BSE

Press Release

Announcement under Regulation 30 (LODR)-Press Release / Media Release

16-Nov-2026 | Source : BSE

Press Release

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

11-Nov-2026 | Source : BSE

Intimation on Schedule of Meetings with Analyst(s)/institutional Investor(s)

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Biocon Ltd. has declared 10% dividend, ex-date: 03 Jul 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Biocon Ltd. has announced 1:1 bonus issue, ex-date: 12 Jun 19

stock-summary
RIGHTS

No Rights history available